(UTC+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna
Find the list of the first speakers confirmed for Innovation for Health 2026
Status: 20 February 2026
Martine van Vugt
Genmab
Executive Vice President and Chief Strategy Officer
Hanne Callewaert
AstriVax Therapeutics
CEO
Ton Logtenberg
Gyes
CEO
Marjon Pasmooij
CBG-MEB
Head of Science Department
Tom van Helmond
Loyens & Loeff
Managing Partner NL
Tim Knotnerus
Agomab
CEO
Sharon Dijksma
Municipality of Utrecht
Mayor
Conny Helder
FAST
Chair of the Board
Kristof Vercruysse
TargED Pharmaceuticals
CEO
Eva van Wanrooij
Johnson & Johnson
VP Regional IP, member global IP leadership team
Anne Sinke
Gilead Sciences
Senior Director, Medical Affairs
Mark Krul
Oncode Accelerator | Aglaia Oncology Fund
CSO | Founder and Director
Barend Bouma
NLO
Partner | European & Dutch Patent Attorney pharma & life sciences
Katja Apelt
The Netherlands Patent Office
IP Advisor
Michel van Agthoven
Johnson & Johnson
Head J&J Campus The Netherlands & Director External Affairs Netherlands
Vincent van der Wel
Orfenix
CEO & Founder
Marcelina Dutkiewicz
Efficiency Tactics
CEO & Founder
Yael Weiss
Mahzi Therapeutics
CEO
Tere Williams
DUB Therapeutics
CEO & Co-founder
JL Ross
Alleo Labs
CEO & Co-founder
Richard van Harderwijk
Quantum Delta
Program Manager Quantum Business Ecosystem
Philippe Bouyer
Quantum Delta
Chair & Director of Research and Technology
Deepak Veeregowda
QT Sense
CEO
Aisling Foley
ExCulture
Co-Founder & CEO
Sjanna Bosma
Health~Holland
International Relations Officer
Nettie Buitelaar
Biotech Booster
Managing Director
Janet Hoogstraate
NorthX Biologics
CEO
Thom Frielink
Curie Capital
Investment Manager
René Kuijten
EQT Group
Partner & Head of EQT Life Sciences
Bernard Mulder
RegMed XB
General Director
Eleanor Price
Thuja Capital
Associate
Nazma Ilahibaks
Jama Tx
CEO & Co-founder
Laura Duran
Health~Holland
International Relations Manager
Miriam Bujny
Sapreme Technologies
Chief Development Officer
Margien Boels
BioGeneration Ventures
Investment Manager FIRST Fund
Iris Kolder
Genmab
Associate Director Translational Data Science
Sonia Hallen
Gilde Healthcare
Investment Manager
Roberto Hofmann
Forbion
Analyst
Nadieh Khalili
Radboudumc
Assistant Professor
Mark Wijsman
Chair
Sangbreeta Moitra
TEDx Awarded Speaker, Behaviour Change Consultant, Leadership & Business Storytelling Expert
Nadiya Ishnazarova
Johnson & Johnson Innovation – JJDC
Senior Director Venture Investments
Hans Gelderblom
LUMC
Professor of Medical Oncology
Mirjam Vollenbroek
University of Twente
Professor & Healthcare Executive
Imran Avci
VU Amsterdam
Associate
Gerard Pasterkamp
UMC Utrecht
Professor of Experimental Cardiology
Gerty Holla
Amsterdam Economic Board
Coalition Manager Life Sciences Health & Biotech
Elmer Maurits
iProtics
CEO & Co-Founder
Jeroen Maas
Philips
Global Director Access to Care Technology and Parterships
Andrew Plank
Roche Nederland
General Manager
Lema Meiwand
Oost NL
Investment Analist Health
Jaap Mannaerts
NLO
Dutch and European Patent Attorney / Partner
Alex Cloherty
Oncode Accelerator
Science Communicator & Marketing & Communications Manager
Eva-Karin Gidlund
NorthX Biologics
Chief Alliance and Innovation Officer
Isa Lindgren
NorthX Biologics
Head of Analytics
Agneta Larhed
RegSmart
Director and Senior Advisor
Lene Gerlach
Hadean Ventures & WiLD
Venture Partner & Founder and Chair of Women
Dan Jing Wu
VivArt-X
CEO & Co-founder
Tero-Pekka Alastalo
Avenue Biosciences
CEO
Bart Baselmans
Hogeschool van Amsterdam
Senior Lecturer
Anke Hövels
KWF
Lead Spearhead Medicines
Rogier van den Braak
Sanquin
Managing Director Sanquin Health Solutions Group
Albertien Greijdanus
Invest-NL
Senior Investment Manager
Friso Smit
Oncode Accelertor
COO & Program Director
Bas Trietsch
MIMETAS
CTO
Christophe Vollgraff
Van Lanschot Kempen
VP Healthcare Investment Banking
Tim Vink
Catalyze
CFO
Maarten Hillen
Catalyze
Sr Consultant Financial Services
Nico van Meeteren
Health~Holland
Executive Director and Secretary General
Cheryl Zimberlin
Oncode Bridge Fund | Ligase BioPartners
Fund Manager
Shobhit Dhawan
Oncode Bridge Fund | Ligase BioPartners
Fund Manager
Sander van der Laan
UMCU
Assistant Professor